Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

SNSE Insider Trading (Sensei Biotherapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $2,065,485.67
Insider Selling (Last 12 Months): $212,883.72

Sensei Biotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Sensei Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sensei Biotherapeutics Share Price & Price History

Current Price: $1.61
Price Change: +0.30 (1.20%)
As of 05/19/2022 01:00 AM ET

This chart shows the closing price history over time for SNSE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Stock With Great Potential
Analyst says this stock could make quick strides with its unbelievable assets.
Learn more

Sensei Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2022James PeyerDirectorBuy1,203$3.20$3,849.60View SEC Filing Icon  
3/1/2022Cambrian Biopharma IncMajor ShareholderBuy2,458$3.60$8,848.80View SEC Filing Icon  
2/28/2022James PeyerDirectorBuy42$3.60$151.20View SEC Filing Icon  
2/24/2022James PeyerDirectorBuy15,000$3.63$54,450.00View SEC Filing Icon  
2/23/2022Cambrian Biopharma IncMajor ShareholderBuy2,500$3.80$9,500.00View SEC Filing Icon  
2/18/2022Cambrian Biopharma IncMajor ShareholderBuy15,000$3.97$59,550.00View SEC Filing Icon  
2/17/2022James PeyerDirectorBuy4,949$4.17$20,637.33View SEC Filing Icon  
2/16/2022Cambrian Biopharma IncMajor ShareholderBuy2,551$4.25$10,841.75View SEC Filing Icon  
2/14/2022Cambrian Biopharma IncMajor ShareholderBuy10,000$4.18$41,800.00View SEC Filing Icon  
2/11/2022Cambrian Biopharma IncMajor ShareholderBuy12,500$4.40$55,000.00View SEC Filing Icon  
2/10/2022James PeyerDirectorBuy5,000$4.58$22,900.00View SEC Filing Icon  
2/8/2022Cambrian Biopharma IncMajor ShareholderBuy10,000$4.33$43,300.00View SEC Filing Icon  
2/4/2022James PeyerDirectorBuy2,500$4.45$11,125.00View SEC Filing Icon  
2/3/2022Cambrian Biopharma IncMajor ShareholderBuy17,500$4.65$81,375.00View SEC Filing Icon  
1/28/2022James PeyerDirectorBuy8,900$4.22$37,558.00View SEC Filing Icon  
1/27/2022Cambrian Biopharma IncMajor ShareholderBuy6,100$4.31$26,291.00View SEC Filing Icon  
1/26/2022James PeyerDirectorBuy29,900$4.62$138,138.00View SEC Filing Icon  
1/25/2022Cambrian Biopharma IncMajor ShareholderBuy20,100$4.86$97,686.00View SEC Filing Icon  
1/24/2022James PeyerDirectorBuy22,707$4.69$106,495.83View SEC Filing Icon  
1/21/2022Cambrian Biopharma IncMajor ShareholderBuy24,703$4.94$122,032.82View SEC Filing Icon  
1/20/2022James PeyerDirectorBuy20,000$5.17$103,400.00View SEC Filing Icon  
1/19/2022Cambrian Biopharma IncMajor ShareholderBuy10,244$4.97$50,912.68View SEC Filing Icon  
1/18/2022James PeyerDirectorBuy10,000$5.08$50,800.00View SEC Filing Icon  
1/14/2022Cambrian Biopharma IncMajor ShareholderBuy6,219$4.99$31,032.81View SEC Filing Icon  
1/13/2022James PeyerDirectorBuy19,953$5.13$102,358.89View SEC Filing Icon  
1/12/2022Cambrian Biopharma IncMajor ShareholderBuy9,202$5.22$48,034.44View SEC Filing Icon  
1/11/2022James PeyerDirectorBuy10,845$5.18$56,177.10View SEC Filing Icon  
12/29/2021Cambrian Biopharma IncMajor ShareholderBuy69,000$4.98$343,620.00View SEC Filing Icon  
12/28/2021James PeyerDirectorBuy11,288$5.28$59,600.64View SEC Filing Icon  
12/27/2021Cambrian Biopharma IncMajor ShareholderBuy3,712$5.30$19,673.60View SEC Filing Icon  
12/23/2021James PeyerDirectorBuy11,000$5.27$57,970.00View SEC Filing Icon  
12/17/2021James PeyerDirectorBuy117$5.29$618.93View SEC Filing Icon  
12/16/2021Cambrian Biopharma IncMajor ShareholderBuy10,925$5.25$57,356.25View SEC Filing Icon  
12/9/2021Thomas G. RicksDirectorBuy20,000$6.62$132,400.00View SEC Filing Icon  
8/11/2021Robert Hamilton PierceInsiderSell16,030$7.34$117,660.20View SEC Filing Icon  
8/9/2021Robert Hamilton PierceInsiderSell6,982$7.06$49,292.92View SEC Filing Icon  
8/6/2021Robert Hamilton PierceInsiderSell6,460$7.11$45,930.60View SEC Filing Icon  
5/5/2021Cambrian Biopharma IncMajor ShareholderBuy350$12.00$4,200.00View SEC Filing Icon  
4/20/2021Cambrian Biopharma IncMajor ShareholderBuy385$12.77$4,916.45View SEC Filing Icon  
4/19/2021James PeyerDirectorBuy1,965$13.38$26,291.70View SEC Filing Icon  
4/13/2021Cambrian Biopharma IncMajor ShareholderBuy2,000$14.00$28,000.00View SEC Filing Icon  
4/7/2021James PeyerDirectorBuy2,000$14.00$28,000.00View SEC Filing Icon  
4/1/2021Cambrian Biopharma IncMajor ShareholderBuy1,000$14.00$14,000.00View SEC Filing Icon  
3/30/2021Cambrian Biopharma IncMajor ShareholderBuy2,000$12.00$24,000.00View SEC Filing Icon  
3/30/2021Cambrian Biopharma IncMajor ShareholderBuy2,000$12.00$24,000.00View SEC Filing Icon  
3/24/2021Cambrian Biopharma IncMajor ShareholderBuy3,750$14.12$52,950.00View SEC Filing Icon  
3/23/2021James PeyerDirectorBuy10,000$14.34$143,400.00View SEC Filing Icon  
3/22/2021Cambrian Biopharma IncMajor ShareholderBuy2,183$15.02$32,788.66View SEC Filing Icon  
3/18/2021Cambrian Biopharma IncMajor ShareholderBuy817$15.25$12,459.25View SEC Filing Icon  
3/8/2021James PeyerDirectorBuy1,000$15.25$15,250.00View SEC Filing Icon  
3/5/2021Cambrian Biopharma IncMajor ShareholderBuy8,000$13.75$110,000.00View SEC Filing Icon  
2/23/2021James PeyerDirectorBuy20,300$17.79$361,137.00View SEC Filing Icon  
2/22/2021Cambrian Biopharma IncMajor ShareholderBuy9,802$18.88$185,061.76View SEC Filing Icon  
See Full Table
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Sensei Biotherapeutics (NASDAQ:SNSE)

11.10% of Sensei Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SNSE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Sensei Biotherapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Jane Street Group LLC10,767$25K0.0%N/A0.035%Search for SEC Filing on Google Icon
5/16/2022State Street Corp225,572$0.52M0.0%+7.3%0.735%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG13,618$31K0.0%-39.2%0.044%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC83,195$0.19M0.0%N/A0.271%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.1,168,011$2.70M0.0%-2.9%3.807%Search for SEC Filing on Google Icon
5/12/2022HighTower Advisors LLC50,229$0.12M0.0%N/A0.164%Search for SEC Filing on Google Icon
5/11/2022Raymond James & Associates13,000$30K0.0%N/A0.042%Search for SEC Filing on Google Icon
5/3/2022Leo Brokerage LLC14,845$34K0.0%N/A0.048%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.1,202,729$6.98M0.0%+20.2%3.931%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN8,783$51K0.0%+14,298.4%0.029%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.11,098$64K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/17/2022Virtu Financial LLC15,980$93K0.0%N/A0.052%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC87,290$0.51M0.0%-66.3%0.285%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC12,804$74K0.0%N/A0.042%Search for SEC Filing on Google Icon
2/14/2022State Street Corp210,292$1.22M0.0%+25.2%0.687%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.11,098$64K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC51,547$0.27M0.0%-8.5%0.168%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC256,518$1.49M0.0%-6.4%0.838%Search for SEC Filing on Google Icon
2/11/2022Charles Schwab Investment Management Inc.43,865$0.26M0.0%-5.8%0.143%Search for SEC Filing on Google Icon
2/10/2022Rhumbline Advisers18,894$0.11M0.0%+14.0%0.062%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.159,778$0.93M0.0%-5.6%0.522%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.6,421$37K0.0%+166.5%0.021%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE25,034$0.15M0.0%+194.0%0.082%Search for SEC Filing on Google Icon
11/19/2021American International Group Inc.11,437$0.12M0.0%+168.1%0.037%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp47,066$0.50M0.0%+155.4%0.154%Search for SEC Filing on Google Icon
11/16/2021Jane Street Group LLC10,773$0.11M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC258,659$2.72M0.0%N/A0.846%Search for SEC Filing on Google Icon
11/16/2021Moore Capital Management LP49,341$0.52M0.0%-61.3%0.161%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC123,258$1.30M0.0%-56.5%0.403%Search for SEC Filing on Google Icon
11/15/2021Royal Bank of Canada2,411$25K0.0%+255.1%0.008%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley3,315$35K0.0%-96.9%0.011%Search for SEC Filing on Google Icon
11/12/2021Tao Capital Management LP32,784$0.35M0.1%N/A0.107%Search for SEC Filing on Google Icon
11/12/2021The Manufacturers Life Insurance Company13,478$0.14M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC273,978$2.88M0.0%+93.2%0.896%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.2,409$25K0.0%+565.5%0.008%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,000,322$10.52M0.0%+175.2%3.270%Search for SEC Filing on Google Icon
11/5/2021Truist Financial Corp70,374$0.74M0.0%N/A0.230%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG12,021$0.13M0.0%+158.3%0.039%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC12,614$0.13M0.0%N/A0.041%Search for SEC Filing on Google Icon
10/13/2021BFT Financial Group LLC14,845$0.16M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley107,726$1.05M0.0%+1,538.4%0.352%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN11,081$0.11M0.0%+365.6%0.036%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC283,667$2.77M0.0%-59.0%0.927%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE11,675$0.12M0.0%-16.4%0.038%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.40,000$0.39M0.0%N/A0.131%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al28,111$0.27M0.0%-75.2%0.092%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley107,726$1.05M0.0%+1,538.4%0.352%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.54,965$0.54M0.0%+18.9%0.180%Search for SEC Filing on Google Icon
8/16/2021State Street Corp100,000$0.98M0.0%+70.2%0.327%Search for SEC Filing on Google Icon
8/13/2021Formula Growth Ltd.100,000$0.98M0.1%+77.7%0.327%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp75,011$0.73M0.0%-8.5%0.245%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC141,809$1.38M0.0%+20.8%0.464%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.387,753$3.78M0.0%+19.4%1.268%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.179,078$1.75M0.0%+15.1%0.585%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp18,431$0.18M0.0%+31.1%0.060%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.363,466$3.55M0.0%+9.2%1.188%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,653$45K0.0%-73.3%0.015%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund5,396$53K0.0%+37.2%0.018%Search for SEC Filing on Google Icon
5/27/2021Davidson Kempner Capital Management LP26,000$0.38M0.0%N/A0.085%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC692,537$10.06M0.0%N/A2.264%Search for SEC Filing on Google Icon
5/18/2021Zimmer Partners LP46,000$0.67M0.0%N/A0.150%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley6,575$96K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al113,353$1.65M0.0%N/A0.371%Search for SEC Filing on Google Icon
5/18/2021Duquesne Family Office LLC100,000$1.45M0.0%N/A0.327%Search for SEC Filing on Google Icon
5/18/2021Davidson Kempner Capital Management LP26,000$0.38M0.0%N/A0.085%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC692,537$10.06M0.0%N/A2.264%Search for SEC Filing on Google Icon
5/18/2021Falcon Edge Capital LP213,658$3.10M0.2%N/A0.699%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System11,494$0.17M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C375,000$5.45M0.1%N/A1.226%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC12,340$0.18M0.0%N/A0.040%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp14,062$0.21M0.0%N/A0.046%Search for SEC Filing on Google Icon
5/12/2021Serengeti Asset Management LP20,000$0.29M0.1%N/A0.065%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp81,947$1.19M0.0%N/A0.268%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC117,406$1.71M0.0%N/A0.384%Search for SEC Filing on Google Icon
5/12/2021Pura Vida Investments LLC67,357$0.94M0.0%N/A0.220%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.155,647$2.26M0.0%N/A0.509%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG2,099$31K0.0%N/A0.007%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund3,934$57K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.332,700$4.83M0.0%N/A1.088%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.4,441$65K0.0%N/A0.015%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Sensei Biotherapeutics logo
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Read More on Sensei Biotherapeutics

Today's Range

Now: $1.61
Low: $1.60
High: $1.65

50 Day Range

MA: $2.02
Low: $1.49
High: $2.81

52 Week Range

Now: $1.61
Low: $1.45
High: $15.12

Volume

80,535 shs

Average Volume

110,181 shs

Market Capitalization

$49.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Sensei Biotherapeutics?

Sensei Biotherapeutics' top insider shareholders include:
  1. Cambrian Biopharma Inc (Major Shareholder)
  2. James Peyer (Director)
  3. Robert Hamilton Pierce (Insider)
  4. Thomas G Ricks (Director)
Learn More about top insider investors at Sensei Biotherapeutics.

Who are the major institutional investors of Sensei Biotherapeutics?

Sensei Biotherapeutics' top institutional shareholders include:
  1. BlackRock Inc. — 3.81%
  2. State Street Corp — 0.74%
  3. Renaissance Technologies LLC — 0.27%
  4. HighTower Advisors LLC — 0.16%
  5. Leo Brokerage LLC — 0.05%
  6. UBS Group AG — 0.04%
Learn More about top institutional investors of Sensei Biotherapeutics stock.

Which major investors are selling Sensei Biotherapeutics stock?

Within the last quarter, SNSE stock was sold by these institutional investors:
  1. BlackRock Inc.
  2. UBS Group AG

Which major investors are buying Sensei Biotherapeutics stock?

Within the previous quarter, SNSE stock was bought by institutional investors including:
  1. Renaissance Technologies LLC
  2. HighTower Advisors LLC
  3. State Street Corp
  4. Leo Brokerage LLC
  5. Raymond James & Associates
  6. Jane Street Group LLC
Within the last year, these company insiders have bought Sensei Biotherapeutics stock:
  1. Cambrian Biopharma Inc (Major Shareholder)
  2. James Peyer (Director)
  3. Robert Hamilton Pierce (Insider)
Learn More investors buying Sensei Biotherapeutics stock.
The Secret to Financial Freedom (True Financial Independence!)
Mark your calendar now...Thursday, June 9, at 8 p.m. ET.

That's when Bill O'Reilly will press stock-picking legend Alexander Green to reveal - for the first time ever - the secret to obtaining truly life-changing wealth in America.

You're Invited to Join FREE - Discover the Secret to True Financial Independence!
>>>